trending Market Intelligence /marketintelligence/en/news-insights/trending/3wep5ObfxLwwMgNabIVVJg2 content esgSubNav
In This List

Oncolix appoints board member

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Oncolix appoints board member

Oncolix Inc. appointed John Holaday as an independent board member.

Holaday's appointment makes him one of two independent directors, fulfilling an OTC-QB listing requirement.

Holaday is the co-founder, and most recently CEO, managing director and board member of QRxPharma Ltd.